BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 38717360)

  • 21. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect.
    Baruch EN; Wang J; Wargo JA
    Cancer Immunol Res; 2021 Apr; 9(4):365-370. PubMed ID: 34003768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbes in the tumor microenvironment: New additions to break the tumor immunotherapy dilemma.
    Zhou L; Fan S; Zhang W; Wang D; Tang D
    Microbiol Res; 2024 Aug; 285():127777. PubMed ID: 38797111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiome as a treatment in colorectal cancer.
    Khan M; Shah S; Shah W; Khan I; Ali H; Ali I; Ullah R; Wang X; Mehmood A; Wang Y
    Int Rev Immunol; 2024; 43(4):229-247. PubMed ID: 38343353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in research on the relationship between the gut microbiome and cancer.
    Song P; Wang QB; Liang B; Jiang SJ
    Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5104-5112. PubMed ID: 34486684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
    Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
    Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Insights Into the Cancer-Microbiome-Immune Axis: Decrypting a Decade of Discoveries.
    Jain T; Sharma P; Are AC; Vickers SM; Dudeja V
    Front Immunol; 2021; 12():622064. PubMed ID: 33708214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
    Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
    Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications.
    Valsecchi AA; Ferrari G; Paratore C; Dionisio R; Vignani F; Sperone P; Vellani G; Novello S; Di Maio M
    Crit Rev Oncol Hematol; 2024 May; 197():104328. PubMed ID: 38490281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy.
    Singh A; Alexander SG; Martin S
    Front Immunol; 2023; 14():1114499. PubMed ID: 37261348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints.
    Shi T; Ma Y; Yu L; Jiang J; Shen S; Hou Y; Wang T
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29735917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota in cancer: insights on microbial metabolites and therapeutic strategies.
    Chen Y; Wang X; Ye Y; Ren Q
    Med Oncol; 2023 Dec; 41(1):25. PubMed ID: 38129370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Microbiota on Tumor Immunotherapy.
    Yu X; Li W; Li Z; Wu Q; Sun S
    Int J Biol Sci; 2024; 20(6):2264-2294. PubMed ID: 38617537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Potential Role of Probiotics in Cancer Prevention and Treatment.
    Yu AQ; Li L
    Nutr Cancer; 2016; 68(4):535-44. PubMed ID: 27144297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.